Lexeo Therapeutics, Inc. (LXEO)

5.755 -0.62 (-9.80%) USD  |  NASDAQ  |  Mar 18, 16:00
5.72 -0.04 (-0.61%) Pre-Market: 08:28
More

Lexeo Therapeutics Total Expenses (Quarterly)

Total Expenses (Quarterly) Chart

View Total Expenses (Quarterly) for LXEO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (Quarterly) Range, Past 5 Years

View Total Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (Quarterly) Benchmarks

View Total Expenses (Quarterly) Benchmarks
Start Trial
Johnson & Johnson Upgrade
Insmed, Inc. Upgrade
Eli Lilly & Co. Upgrade
Madrigal Pharmaceuticals, Inc. Upgrade
Phathom Pharmaceuticals, Inc. Upgrade

Total Expenses (Quarterly) Related Metrics

Net Income (Quarterly) Upgrade
EPS Diluted (Quarterly) Upgrade
Enterprise Value Upgrade
Earnings Yield Upgrade
Normalized Earnings Yield Upgrade